Resources for You
Augmentin XR (amoxicillin/clavulanate potassium) Extended Release Tablets December 2008
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2008
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.|
- Hypersensitivity Reactions
- hypersensitivity vasculitis
- ...hepatitis and cholestatic jaundice, (see CONTRAINDICATIONS)...